Perego G - Search Results

1

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis.

Petrelli F, Cherri S, Ghidini M, Perego G, Ghidini A, Zaniboni A. Petrelli F, et al. Among authors: perego g. World J Methodol. 2021 May 20;11(3):95-109. doi: 10.5662/wjm.v11.i3.95. eCollection 2021 May 20. World J Methodol. 2021. PMID: 34026583 Free PMC article.

2

Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.

Petrelli F, Ghidini M, Ghidini A, Perego G, Cabiddu M, Khakoo S, Oggionni E, Abeni C, Hahne JC, Tomasello G, Zaniboni A. Petrelli F, et al. Among authors: perego g. Cancers (Basel). 2019 Aug 14;11(8):1174. doi: 10.3390/cancers11081174. Cancers (Basel). 2019. PMID: 31416208 Free PMC article.

3

Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma.

Consoli F, Bersanelli M, Perego G, Grisanti S, Merelli B, Berruti A, Petrelli F. Consoli F, et al. Among authors: perego g. Clin Transl Oncol. 2020 Jun;22(6):900-907. doi: 10.1007/s12094-019-02207-7. Epub 2019 Sep 25. Clin Transl Oncol. 2020. PMID: 31555967

4

Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?

Perego G, Nozza R, Oggionni E, Cabiddu M, Scolari C, Omati E, Castelli EA, Petrelli F. Perego G, et al. J Oncol Pharm Pract. 2020 Jun;26(4):967-971. doi: 10.1177/1078155219900913. Epub 2020 Feb 10. J Oncol Pharm Pract. 2020. PMID: 32041467

5

A systematic review of salvage therapies in refractory metastatic colorectal cancer.

Petrelli F, Perego G, Ghidini A, Ghidini M, Borgonovo K, Scolari C, Nozza R, Rampulla V, Costanzo A, Varricchio A, Rausa E, Pietrantonio F, Zaniboni A. Petrelli F, et al. Among authors: perego g. Int J Colorectal Dis. 2020 May;35(5):783-794. doi: 10.1007/s00384-020-03571-5. Epub 2020 Mar 26. Int J Colorectal Dis. 2020. PMID: 32219509

6

Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis.

Petrelli F, Iaculli A, Signorelli D, Ghidini A, Dottorini L, Perego G, Ghidini M, Zaniboni A, Gori S, Inno A. Petrelli F, et al. Among authors: perego g. J Clin Med. 2020 May 13;9(5):1458. doi: 10.3390/jcm9051458. J Clin Med. 2020. PMID: 32414103 Free PMC article.

7

Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy.

Perego G, Barzaghi P, Vavassori I, Petrelli F. Perego G, et al. Med Oncol. 2020 Aug 7;37(9):81. doi: 10.1007/s12032-020-01408-3. Med Oncol. 2020. PMID: 32767163

8

Past, present and future use of cytotoxic agents in oncology practice: A systematic review of Pubmed and ClinicalTrials.gov databases.

Petrelli F, Damato A, Perego G, Ghidini A, Daniele G, Pinto C. Petrelli F, et al. Among authors: perego g. J Oncol Pharm Pract. 2020 Dec;26(8):2069-2072. doi: 10.1177/1078155220951237. Epub 2020 Aug 20. J Oncol Pharm Pract. 2020. PMID: 32819200 No abstract available.

9

Association of steroid use with survival in solid tumours.

Petrelli F, Bukovec R, Perego G, Luisa R, Luciani A, Zaniboni A, Ghidini A. Petrelli F, et al. Among authors: perego g. Eur J Cancer. 2020 Dec;141:105-114. doi: 10.1016/j.ejca.2020.09.020. Epub 2020 Oct 30. Eur J Cancer. 2020. PMID: 33130548

10

Surrogate endpoints for new anti-cancer drugs approvals: Are we follow the right way?

Perego G, Petrelli F. Perego G, et al. J Oncol Pharm Pract. 2021 Mar;27(2):448-449. doi: 10.1177/1078155220984834. Epub 2020 Dec 29. J Oncol Pharm Pract. 2021. PMID: 33375904 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters